Details for 2016869301

Up to date per 01.04.2026

Actions

Title / Product Name

CYP26-RESISTENTEN RAR-ALPHA-SELEKTIVEN AGONISTEN BEI DER BEHANDLUNG VON KREBS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2016869301

EP Publication Number

3380086

E-Number

1437641

Language

PCT Number

US16063659

Publication Date

03.10.2018 A

13.10.2021 B1

Registration Date

13.10.2021

AT Publication Date

15.11.2021

Application Date

23.11.2016

Registration Number

Priorities

25.11.2015

201562260098 P

IPC

A61K 31/196 20060101AFI20210419BHEP

Maximum Duration of Protection

23.11.2036

Owner

IO Therapeutics, Inc.9450 Pinecrest Drive, Unit 9497 Spring, TX 77380US

The Johns Hopkins University3400 North Charles Street Baltimore, MD 21218US

Representative

Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT

Inventor

GHIAUR, Gabriel3400 N. Charles Street Baltimore, MD 21218US

JONES, Richard, J.3400 N. Charles Street Baltimore, MD 21218US

ALONSO, Salvador449 Canal St. Apt. 308 Somerville, MA 02145US

CHANDRARATNA, Roshantha, A.26242 Via Corrizo San Juan Capistrano, CA 92675US

Information about Fees